Indications and Purposes
| 1 Indications And Usage Abilify Oral Tablets, Orally-Disintegrating Tablets, And Oral Solution Are Indicated For The Treatment Of: Schizophrenia [See Clinical Studies (14.1) ] Acute Treatment Of Manic And Mixed Episodes Associated With Bipolar I Disorder [See Clinical Studies (14.2) ] Adjunctive Treatment Of Major Depressive Disorder [See Clinical Studies (14.3) ] Irritability Associated With Autistic Disorder [See Clinical Studies (14.4) ] Treatment Of Tourette's Disorder [See Clinical Studies (14.5) ] Abilify Injection Is Indicated For The Treatment Of: Agitation Associated With Schizophrenia Or Bipolar Mania [See Clinical Studies (14.6) ] Abilify Is An Atypical Antipsychotic. The Oral Formulations Are Indicated For: Schizophrenia ( 14.1 ) Acute Treatment Of Manic And Mixed Episodes Associated With Bipolar I ( 14.2 ) Adjunctive Treatment Of Major Depressive Disorder ( 14.3 ) Irritability Associated With Autistic Disorder ( 14.4 ) Treatment Of Tourette's Disorder ( 14.5 ) The Injection Is Indicated For: Agitation Associated With Schizophrenia Or Bipolar Mania ( 14.6 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Aripiprazole |
|
ZINC1851149 |